From Rarity to Reality: Osimertinib's Promising Horizon in Treating Uncommon EGFR Mutations in Non-Small Cell Lung Cancer.
Article in Clinical Cancer Research (May 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (May 2024)
Article in Journal of Personalized Medicine (March 2023)
Preprint in Research Square (March 2022)